[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

GX Cybersecurity ETF (BUG)

GX Cybersecurity ETF (BUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 Ways to Invest in Cybersecurity Through ETFs

BUG, IHAK, and WCBR are similarly priced cybersecurity ETFs, but differences in holdings, concentration, and growth screens explain their varied 2026 performance and risk levels.

QLYS : 181.80 (-0.23%)
CRWD : 190.09 (-0.13%)
WCBR : 39.27 (+0.69%)
BUG : 40.36 (+0.57%)
BAH : 77.21 (+1.11%)
NTSK : 14.43 (+0.35%)
IHAK : 63.16 (+0.19%)
PANW : 357.50 (+2.27%)
RBRK : 99.14 (+1.66%)
Gen Digital Stock: Analyst Estimates & Ratings

While Gen Digital has underperformed relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

GEN : 28.79 (+2.20%)
BUG : 40.36 (+0.57%)
$SPX : 7,681.64 (+0.53%)
Cybersecurity ETFs Are Rallying While AI Stocks Cool Off

Cybersecurity stocks rallied in Q2 2026, boosting ETFs like WCBR, HACK and BUG, which posted YTD gains of 35%, 34% and 29%, respectively, amid differing fees and holdings.

HACK : 110.68 (+0.83%)
CRWD : 190.09 (-0.13%)
WCBR : 39.27 (+0.69%)
BUG : 40.36 (+0.57%)
Cybersecurity Demand Is High—Yet This ETF Is on Sale

Despite tech’s ongoing sell-off, the cybersecurity sector’s outlook remains strong. The BUG ETF offers discounted exposure to top firms as demand surges.

CRWD : 190.09 (-0.13%)
BUG : 40.36 (+0.57%)
FTNT : 152.48 (+1.12%)
AKAM : 110.25 (+0.15%)
PANW : 357.50 (+2.27%)
Missed the AI Rally? Jefferies Says CrowdStrike and These 3 Other Cybersecurity Stocks Could Be Next

Cybersecurity stocks have trailed the tech rally, but Jefferies sees 2026 as the year market leaders begin to separate from the pack.

VGT : 118.36 (+0.09%)
CRWD : 190.09 (-0.13%)
BUG : 40.36 (+0.57%)
AVPT : 13.23 (+0.76%)
ZS : 178.85 (+2.23%)
PANW : 357.50 (+2.27%)
CyberArk, SentinelOne, Zscaler Get Analyst Thumbs Up — Retail Bets Are Stronger On 2 Cybersecurity Stocks

Stephens analysts see upside potential, ranging from 30% to 38%, for these 3 cybersecurity stocks.

S : 20.98 (+0.19%)
BUG : 40.36 (+0.57%)
ZS : 178.85 (+2.23%)
CYBR : 408.85 (-0.09%)
SentinelOne Stock Slips As Lackluster Guidance Takes Sheen Off Solid Q4 Print: Retail Mood Hits Rock Bottom

The company said it is on track to surpass $1 billion in ARR and revenue in the new fiscal year.

S : 20.98 (+0.19%)
BUG : 40.36 (+0.57%)
IHAK : 63.16 (+0.19%)
SentinelOne Stock Snags Price Target Cut Ahead Of Q4 Results: Retail Mood Stays Downbeat

JPMorgan said its industry conversations were mixed to slightly positive for the quarter but cut its price target due to a contraction in peer multiples.

S : 20.98 (+0.19%)
BUG : 40.36 (+0.57%)
IHAK : 63.16 (+0.19%)
Zscaler Stock Jumps Premarket After Beat-And-Raise Q2: Retail Optimism Abounds

CEO Jay Chaudhry said the growing adoption of Zero Trust and AI drove strong demand for the company’s platform.

QQQ : 713.27 (+0.33%)
BUG : 40.36 (+0.57%)
ZS : 178.85 (+2.23%)
Investors Eye Zscaler’s Q2 Results After Rival Crowdstrike’s Mixed Print: Retail Stays Bullish

The guidance issued in early December calls for $0.68 to $0.69 in EPS on revenue of $633 million to $635 million.

QQQ : 713.27 (+0.33%)
BUG : 40.36 (+0.57%)
ZS : 178.85 (+2.23%)

Barchart Exclusives

NVAX Stock Alert: Biotechs Hit Post-Pandemic High on mRNA Cancer Breakthrough
NVAX stock surges amid biotech stock rally following Moderna and Merck cancer breakthrough. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.